CN107280008A - A kind of dietary supplements and its preparation method and application - Google Patents
A kind of dietary supplements and its preparation method and application Download PDFInfo
- Publication number
- CN107280008A CN107280008A CN201710535181.1A CN201710535181A CN107280008A CN 107280008 A CN107280008 A CN 107280008A CN 201710535181 A CN201710535181 A CN 201710535181A CN 107280008 A CN107280008 A CN 107280008A
- Authority
- CN
- China
- Prior art keywords
- dietary supplements
- folium artemisiae
- artemisiae argyi
- oleuropein
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 105
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000000284 extract Substances 0.000 claims abstract description 75
- 235000011576 oleuropein Nutrition 0.000 claims abstract description 73
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 claims abstract description 65
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 claims abstract description 65
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 claims abstract description 65
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 claims abstract description 64
- 239000000047 product Substances 0.000 claims abstract description 27
- 239000000463 material Substances 0.000 claims abstract description 22
- 230000036541 health Effects 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 18
- 235000005911 diet Nutrition 0.000 claims abstract description 7
- 230000000378 dietary effect Effects 0.000 claims abstract description 4
- 239000002552 dosage form Substances 0.000 claims abstract description 4
- 239000003937 drug carrier Substances 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 34
- 206010028980 Neoplasm Diseases 0.000 claims description 29
- 201000010099 disease Diseases 0.000 claims description 29
- 201000011510 cancer Diseases 0.000 claims description 26
- 230000036542 oxidative stress Effects 0.000 claims description 26
- 241000196324 Embryophyta Species 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 206010012601 diabetes mellitus Diseases 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 17
- 240000007817 Olea europaea Species 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- 238000005516 engineering process Methods 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 13
- 230000000451 tissue damage Effects 0.000 claims description 12
- 231100000827 tissue damage Toxicity 0.000 claims description 12
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 9
- 230000003064 anti-oxidating effect Effects 0.000 claims description 9
- 230000002265 prevention Effects 0.000 claims description 9
- 208000024891 symptom Diseases 0.000 claims description 9
- 210000001367 artery Anatomy 0.000 claims description 8
- 230000032683 aging Effects 0.000 claims description 7
- 235000019504 cigarettes Nutrition 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 235000010894 Artemisia argyi Nutrition 0.000 claims description 4
- 208000035150 Hypercholesterolemia Diseases 0.000 claims description 4
- 208000034189 Sclerosis Diseases 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 230000033001 locomotion Effects 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 208000037976 chronic inflammation Diseases 0.000 claims description 3
- 230000006020 chronic inflammation Effects 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims description 2
- 240000008384 Capsicum annuum var. annuum Species 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 244000030166 artemisia Species 0.000 claims description 2
- 239000006186 oral dosage form Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 21
- 239000003963 antioxidant agent Substances 0.000 abstract description 20
- 235000006708 antioxidants Nutrition 0.000 abstract description 20
- 239000000203 mixture Substances 0.000 abstract description 13
- 230000001741 anti-phlogistic effect Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 description 43
- 150000003254 radicals Chemical class 0.000 description 26
- 206010061218 Inflammation Diseases 0.000 description 25
- 230000004054 inflammatory process Effects 0.000 description 24
- 150000001875 compounds Chemical class 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 17
- 238000011160 research Methods 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 235000019197 fats Nutrition 0.000 description 15
- 239000010408 film Substances 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 230000008569 process Effects 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 229910002092 carbon dioxide Inorganic materials 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 10
- 206010009944 Colon cancer Diseases 0.000 description 9
- 238000003915 air pollution Methods 0.000 description 9
- 230000001093 anti-cancer Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 230000003647 oxidation Effects 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 9
- 208000008589 Obesity Diseases 0.000 description 8
- 230000001684 chronic effect Effects 0.000 description 8
- 229930003935 flavonoid Natural products 0.000 description 8
- 235000017173 flavonoids Nutrition 0.000 description 8
- 150000002215 flavonoids Chemical class 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 235000012054 meals Nutrition 0.000 description 8
- 235000020824 obesity Nutrition 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- -1 radiation Substances 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 6
- 201000001320 Atherosclerosis Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 208000029742 colonic neoplasm Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 230000000391 smoking effect Effects 0.000 description 6
- 208000024827 Alzheimer disease Diseases 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 5
- 208000026310 Breast neoplasm Diseases 0.000 description 5
- 206010008190 Cerebrovascular accident Diseases 0.000 description 5
- 208000001145 Metabolic Syndrome Diseases 0.000 description 5
- 244000203593 Piper nigrum Species 0.000 description 5
- 235000008184 Piper nigrum Nutrition 0.000 description 5
- 208000006011 Stroke Diseases 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 5
- 206010003246 arthritis Diseases 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000013614 black pepper Nutrition 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 150000002338 glycosides Chemical class 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 150000002989 phenols Chemical class 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 102000004889 Interleukin-6 Human genes 0.000 description 4
- 108090001005 Interleukin-6 Proteins 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 239000000809 air pollutant Substances 0.000 description 4
- 231100001243 air pollutant Toxicity 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 229940100601 interleukin-6 Drugs 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 235000004330 tyrosol Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 108010074051 C-Reactive Protein Proteins 0.000 description 3
- 102100032752 C-reactive protein Human genes 0.000 description 3
- 101150038243 CLOCK gene Proteins 0.000 description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- 230000007067 DNA methylation Effects 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000005907 cancer growth Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000027288 circadian rhythm Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000008821 health effect Effects 0.000 description 3
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 208000015122 neurodegenerative disease Diseases 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- 108010088547 ARNTL Transcription Factors Proteins 0.000 description 2
- 241001435059 Artemisia argyi Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 2
- 101000710899 Homo sapiens Cannabinoid receptor 1 Proteins 0.000 description 2
- 101001116937 Homo sapiens Protocadherin alpha-4 Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061216 Infarction Diseases 0.000 description 2
- 235000019510 Long pepper Nutrition 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 235000002725 Olea europaea Nutrition 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 240000003455 Piper longum Species 0.000 description 2
- 208000001280 Prediabetic State Diseases 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 102100024261 Protocadherin alpha-4 Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000006937 anti-inflammatory bioactivity Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000007211 cardiovascular event Effects 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 230000032677 cell aging Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000000909 electrodialysis Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000008753 endothelial function Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 108091005995 glycated hemoglobin Proteins 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 210000000110 microvilli Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 description 2
- 235000002577 monoterpenes Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 229920001197 polyacetylene Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 201000009104 prediabetes syndrome Diseases 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 239000012744 reinforcing agent Substances 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 101150022210 tim gene Proteins 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 230000003827 upregulation Effects 0.000 description 2
- 238000007738 vacuum evaporation Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- 102100037211 Aryl hydrocarbon receptor nuclear translocator-like protein 1 Human genes 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 208000017164 Chronobiology disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- VGAJNILINWUWOP-UHFFFAOYSA-N Eudesmane Natural products COC(=O)C(=C)C1C(O)C2C(=O)CCC(O)C2(C)CC1OC(=O)C(=C)CO VGAJNILINWUWOP-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000882921 Homo sapiens Circadian locomoter output cycles protein kaput Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 208000032818 Microsatellite Instability Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 101710184528 Scaffolding protein Proteins 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010041290 Soft tissue inflammation Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003527 anti-angiogenesis Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000006944 antioxidant bioactivity Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000004618 arterial endothelial cell Anatomy 0.000 description 1
- 208000037849 arterial hypertension Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960002233 benzalkonium bromide Drugs 0.000 description 1
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960002152 chlorhexidine acetate Drugs 0.000 description 1
- 230000008632 circadian clock Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- DYEQPYSFRWUNNV-APIJFGDWSA-N eudesmane Chemical compound C1CC[C@@H](C)[C@@H]2C[C@H](C(C)C)CC[C@]21C DYEQPYSFRWUNNV-APIJFGDWSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000010462 extra virgin olive oil Substances 0.000 description 1
- 235000021010 extra-virgin olive oil Nutrition 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000008798 inflammatory stress Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 235000015250 liver sausages Nutrition 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000021084 monounsaturated fats Nutrition 0.000 description 1
- 210000001256 muscle mitochondria Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000029522 neoplastic syndrome Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 101150008094 per1 gene Proteins 0.000 description 1
- 230000003617 peroxidasic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920005547 polycyclic aromatic hydrocarbon Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000007111 proteostasis Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 229940092385 radish extract Drugs 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002832 shoulder Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000012232 skeletal muscle contraction Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 239000011882 ultra-fine particle Substances 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000001196 vasorelaxation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000010463 virgin olive oil Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a kind of dietary supplements, including 60 80 parts of Folium Artemisiae Argyi extracts, 10 20 parts of oleuropeins and 10 20 parts of piperings.The dietary supplements of the present invention can further comprise upper dietetic product and/or pharmaceutically acceptable carrier and/or auxiliary material peroral dosage form is made.The preparation method of the dietary supplements of the present invention is to prepare Folium Artemisiae Argyi extract, oleuropein and pipering according to predetermined ratio;And mix Folium Artemisiae Argyi extract, oleuropein and pipering.The dietary supplements of the present invention has remarkable anti-oxidant and antiphlogistic effects, available for preparing health products and medicine.
Description
Technical field
The invention belongs to medicines and health protection field, in particular it relates to a kind of dietary supplements and preparation method thereof and
Using.
Background technology
Today, include ischemic heart disease, apoplexy, cancer, glycosuria to the most common reason of dead related disease
Disease, hypertension, arthritis, obesity, chronic obstructive pulmonary disease (COPD) and other cigarettes and air pollution relevant disease, nerve are moved back
Row disease such as Alzheimer's disease and Parkinson's disease.
Have confirmed, above-mentioned many diseases can be prevented.Such prevention can be based on several factors, wherein a lot
It is relevant with heredity, diet, life style and environmental problem.
Inflammation.Today, the common factor and a series of pathology of referred to as inflammation of many most common and serious diseases
Process is relevant.Chronic body inflammation, which is one, is used for the broad terms of a series of reaction of body chemistries and phenomenon, and it is to body
Metabolic state and process have significant impact.
Inflammation is beneficial to human body.Body can produce a series of to the inflammation that sunburn, influenza virus or skin burn are caused
The reaction of immunology and the circulatory system, to repair skin injury or influenza related tissue damage.Therefore under many circumstances, it is scorching
Disease is beneficial to body.
However, inflammation and the generation and exacerbation of specified disease that chronic body illness is produced have very big relation.It is cardiovascular
Disease, cancer, arterial hypertension, diabetes, metabolic syndrome, hypercholesterolemia, arthritis, obesity and Alzheimer
Disease all has shown that relevant with the abnormal rise of chronic internal inflammation.Can be to specific biomarker, particularly C- reaction eggs
In vain (CRP), measure to prove these inflammation.
Inflammation is also likely to be the direct result of intensive to calorie, natural deletions fiber excessive food consumption, this increase
The risk of increased weight.Such increased weight can produce the accumulation of stomach fat and interior fat.Excessive stomach fat
Increase with interior fat and the yield for the inflammatory molecule for being referred to as cell factor that can enter the circulatory system has very big
Relation.So, they can cause the inflammatory response of body, so as to increase the risk of relevant disease.
A kind of most obvious inflammatory molecule that stomach fat is produced is interleukin-6 (IL-6).From consumption belly fat
The vein of fat receives in the portal vein of blood and has measured high-caliber IL-6.In addition, high-caliber IL-6 and high blood water
Flat CRP is directly related.
Disease caused by a kind of common and inflammation that is known is atherosclerosis.Circulate inflammatory cytokine chemical combination
Thing may change the integrality of the crucial vascular endothelial cell of body, the coronary artery of such as heart and the arteria carotis of neck.With
Inflammatory response afterwards promotes the abnormal accumulation of the fat cell of arterial endothelial cell.Such case is referred to as Atherosclerosis
Change, if developing as one pleases can cause blood vessel diameter to significantly reduce to cause perfused tissue not enough.
Fat aggregation in vascular wall is referred to as patch.In some cases, especially in height inflammatory conditions or experience
During oxidative stress, unstable patch may lose its integrality, cause plaque rupture.This phenomenon and the spot from damage
Block is relevant and ultimately causes thrombosis, and wherein thrombus is clot.Such Arterial thrombosis is to cause most heart
The reason for a variety of apoplexy.
Chronic body inflammation is relevant with elevated fasting blood glucose level, while also relevant with the increase of glycated hemoglobin.It is super
Weight and obese individuals not coincidence, because excessive internal organ and stomach fat also can be to the works of the circulation insulin produced by pancreas
With resistance is produced, the long-term rise of blood sugar level is ultimately resulted in.This is referred to as diabetes B.
Also easily increase suffers from the risk of malignant tumour to patient with chronic body inflammation.With other healthy individual body phases
Than, some most common human cancers, including lung cancer, colorectal cancer, breast cancer, liver cancer, stomach cancer and prostate cancer, easily send out
Life is with the increased chronic body inflammatory patients of level.
Researcher is it has been proved that individual body phase of the patient with Alzheimer's disease and Parkinson's disease with being not suffering from these diseases
Than with higher levels of level of inflammation.
Oxidative stress.In human body, the physiology course referred to as aoxidized is vital for production energy.So
And, during production energy, it can also produce free radical derived from oxygen.Sometimes the generation of such free radical is uncontrolled simultaneously
The histocyte of the mankind may be damaged.
Under normal physiological conditions, atom has paired outer-shell electron, and therefore unobvious to adjacent tissue
Reactivity.Free radical is defined as substantially increasing its tissue reactive containing not paired electronics.In biotic environment
Under, due to these free radical atoms or compound may not make any distinction between with neighbouring molecule and cell effect, therefore from
It is probably breakneck by this tissue reactive of base.
Free radical may produce referred to as " electronic theft " (electron stealing) phenomenon, and the phenomenon causes tissue
Aoxidize and destination organization molecule may be made to lose activity.If the concentration of free radical is sufficiently large, these reactions are likely to result in
Extensive cellular damage.
Oxidative stress simplest form is likely to be harmful tissue-damaging process, and the process is having excessive free free
Base or lack anti-oxidizing compounds or this in two situation occur in the presence of simultaneously.Damaged as caused by free free radical activity is out of control
Wound is referred to as oxidative stress.
The scope of this tissue damage can be conditioned or reduce, and be utilized depending on anti-oxidizing compounds Relative biological is neutralized
Degree.These antioxidants are directly with free radical reaction and neutralizing their reactivity, linked groups' poison with low degree
Property.
Oxidative stress may also result in the oxide-containing chemical material excess for being referred to as active oxygen (ROS).The drastically liter of ROS concentration
It is high that there may be obvious cellular damage.
Oxidative stress may be produced by many reasons, including diet is bad, toxin, radiation, medicine and air pollution.The world
The surrounding air in upper many areas contains a large amount of pollutants.It even itself may be exactly free to have some in these air pollutants
Free radical, such as nitrogen dioxide.The result of these air pollutants of acute and Long Term Contact is that oxidative stress occurs for lung, once
Pollutant is drawn through and into the circulatory system, and the oxidative stress that lung occurs can further result in systemic oxidative stress.
Lung's oxidative stress caused by air pollution can further trigger wider inflammatory reaction, then can in body
It can discharge more free radicals.In the case where lacking enough polyphenoils, this tissue damage would is that significantly.
Especially, endonuclear DNA can be influenceed by being related to the free radical tissue damage of cell tissue nucleic acid.Therefore, for a long time
Contact stain thing can trigger cell effect therewith, and some of which cell effect can trigger cancer.
Particulate air pollutant, especially gas-kinetic diameter are less than 10 μm of particle, are special for human health
Dangerous, because they can cause significant oxidative stress and free radical to produce.
If developed as one pleases, this particulate air pollutant can also cause the damage of significant bodily tissue, local and complete
The inflammation of body, and ultimately form cancer cell and trigger other inflammation related diseases.
In some areas, air pollution has become chief city human health problems.Particularly, air pollution particle
Different sizes and composition they endanger human healths ability in especially their induced oxidations stress ability in play
Remarkable effect.Ultrafine particle and other fine particulate materials less than 0.1 μm may be inhaled into and thin by the macrophage of body
Born of the same parents and epithelial cell absorb.This absorption is likely to induce human body oxidative stress.
In addition, other air pollution compounds, such as polycyclic aromatic hydrocarbon (PAH), also materially increasing oxidation should
Swash the risk with final tissue damage.
Anti-oxidant compounds, such as polyphenol and flavonoids, with the ability for removing these free radicals, it is meant that their energy
Enough neutralize the harm that these free radicals are caused to human cell.In this case, these nutrient for plants, polyphenol and flavonoids
Reduce the harm of cell that free radical causes and tissue damage.
The neutralization of free radical can bring a variety of benefits to human body.These benefits include reducing following disease or symptom
Risk:Coronary heart disease, cardiovascular and cerebrovascular disease, cancer and other neoplastic syndromes, diabetes, obesity, nerve degenerative diseases, pass
Section is scorching, pollution is related to smoking tissue damage and the tissue aging of acceleration.
Another elevated common reason of interior free yl concentration is muscular training, particularly the exercising with oxygen of high intensity.
Increased Skeletal Muscle Contraction produces a large amount of excessive free radical compounds.
The generation of this free radicals a large amount of caused by motion, hinders ability to act of the muscle in optimum level, extends
The recovery period of overexercise, and may improve the danger of muscle damage, it is referred to as pulled muscle or muscle tear.
The clinical research for performing high intensity interval tranining (HIIT) sportsman is shown, when sportsman takes oral anti-oxidant
During agent, its energy production and athletic performance are optimal.It has been shown that HIIT its there is suppression to be referred to as the bones of human body " energy plants "
The ability of bone Muscle Mitochondria, to eliminate the accumulation of the free radical related to moving.
The content of the invention
Technical problem solved by the invention is lacked in the prior art while having anti-oxidant and antiinflammatory action and in people
The high dietary supplements of internal bioavailability.In order to solve the technical problem, the invention provides a kind of dietary supplements
And its preparation method and application.
On the one hand, the invention provides a kind of dietary supplements, count by weight, the dietary supplements includes:60-
80 parts of Folium Artemisiae Argyi extracts, 10-20 parts of oleuropeins and 10-20 parts of piperings.
Foregoing dietary supplements, is counted by weight, and the dietary supplements includes:65-75 parts of Folium Artemisiae Argyi extracts,
12-18 parts of oleuropeins and 12-18 parts of piperings.
Foregoing dietary supplements, is counted by weight, and the dietary supplements includes:70 parts of Folium Artemisiae Argyi extracts, 15 parts
Oleuropein and 15 parts of piperings.
Foregoing dietary supplements, the Folium Artemisiae Argyi extract extracts from the whole aerial part of folium artemisiae argyi plant.
Foregoing dietary supplements, the oleuropein extracts from olive fruits, olive water extract and/or olive oil.
Foregoing dietary supplements, the dietary supplements further comprises that dietetic product is upper and/or can pharmaceutically connect
The carrier and/or auxiliary material received.
Foregoing dietary supplements, the dietary supplements is made into peroral dosage form;Preferably, the peroral dosage form is scattered
Agent, tablet, capsule, granule, oral liquid or pill.
On the other hand, the invention provides the preparation method of foregoing dietary supplements, the preparation method includes:According to
Predetermined ratio prepares Folium Artemisiae Argyi extract, oleuropein and pipering;And mix Folium Artemisiae Argyi extract, oleuropein and pipering
Close.
Foregoing preparation method, the Folium Artemisiae Argyi extract uses supercritical CO2Abstraction technique and/or moisture film extraction filtering skill
Art is prepared.
Foregoing preparation method, the oleuropein is prepared using moisture film extraction filtering technique.
Foregoing preparation method, the pipering uses supercritical CO2Abstraction technique is prepared.
On the other hand, health products or medicine with antioxidation are being prepared the invention provides foregoing dietary supplements
Application in product.
On the other hand, health products or medicine with antiinflammatory action are being prepared the invention provides foregoing dietary supplements
In application.
On the other hand, the invention provides foregoing dietary supplements prepare prevention and/or treat it is following any one
Or the application in the health products or medicine of a variety of diseases or symptom:Oxidative stress, chronic inflammation, angiocardiopathy (CVD), artery
Hardening, cancer, Arterial Hypertention, diabetes, Health cost caused by hypercholesterolemia and similar relevant disease, cigarette,
Oxidative stress and tissue damage, age-related body aging, overweight and fat, bacterium infection, nerve are moved back caused by pollution
Loss and motion loss that row disease, skin symptom, ultraviolet trigger.
The beneficial effects of the invention are as follows:The present invention dietary supplements is anti-oxidant and antiphlogistic effects significantly, to it is a variety of with it is scorching
Disease or the related disease of oxidative stress or symptom have good prevention or therapeutic action.The dietary supplements of the present invention, which has, matches somebody with somebody
Fang Xinying, it is with low cost, evident in efficacy, the advantages of have no toxic side effect, and be applicable to industrialized production.
Embodiment
In order to be fully understood by the purpose of the present invention, feature and effect, by following embodiments, detailed is made to the present invention
Describe in detail bright.The process of the present invention is in addition to the description below, and remaining is using the conventional method or device of this area.
Folium artemisiae argyi (Artemisia argyi)
Folium artemisiae argyi is, in the widely distributed herbaceos perennial of China, and to have been used to treatment infection, inflammatory disease, malaria
Disease, diarrhoea, hepatitis, cancer [Adams M, Efferth T , &Bauer R.Artemisia argyi.Planta Medica,
2006;72:862-864.;Cai P.Lishizhen Medicine and Materia Medica Research, 2001;1:
1137-1139;Khan, et al.Evidence-Based Complementary and Alternative Medicine,
2012] and in the traditional Chinese medicine of dyshaemia.
Describe the plant chemical ingredient of this plant and numerous researchs of pharmacological property have shown that it contains many lifes
Thing reactive compound.These bioactive compounds include cumarin, glycoside, flavonoids, polyacetylene, monoterpene, sterol, three
Terpene, Sesquiterpene and essential oil.
The biological effect that some of these bioactive compounds have been confirmed includes:Anti-diabetic [Adams JD,
Garcia C , &Garg G, Chinese Medicine, 2012;3:116-123], anti-oxidant [Ferreira JF, et
Al.Molecules, 2010;15(5):3135-3170], anti-proliferate, anti-inflammatory [Cai P.Lishizhen Medicine and
Materia Medica Research, 2001;1:1137-1139], anticancer, antiallergy [Ji HY, et al, Molecules,
2010;15(9):6466-6475], and antiulcer [Yoon KD, Chin YW, Yang, MH , &Kim J.Food Chemistry,
2011;129:679-683].
Have confirmed, flavone compound has anticancer and anti-proliferate characteristic.Especially, flavones known to two kinds has shown
Referred to as SW 620 human cancer cell line's growth can be suppressed by showing.SW 620 is derived from human colon cancer cell.
Anticancer effect known to folium artemisiae argyi can suppress the growth of human colon cancer cell in two ways.They directly suppress knot
Colon-cancer cell is bred, also, they also suppress angiogenesis, thus prevent the cancer life generally induced by colon cancer maintain and
New vessels is formed.
Oleuropein (Oleuropein (OL))
Oleuropein (OL) is main bitter taste secoiridoid glycoside family phenolic compounds.Its derivative includes 2 kinds of masters
The olive source alcohols wanted:1.3,4- dihydroxyphenyl ethanols, also referred to as oleuropein (HT), and 2. tyrosols, also referred to as
Tyrosol (TY).
OL is present in the olive leaf without processing with the olive fruits before maturation, passes through chemistry after fruit maturation
Method and enzyme process, which decompose OL, can produce HT and TY.
OL is hydrophilic compounds, therefore, the concentration in virgin oil (VOO) and Extra Virgin (EVOO)
It is very low.
Oleuropein has a variety of health benefits having confirmed and medical application.For example:
It is anti-oxidant.OL contains positively charged oxygen on its phenol carbocyclic ring, and OL chemical constitution makes it have removing free radical
Ability and can be as protecting barrier of the human body from tissue damage and aging.
Anti-aging.Effects of the ROS to tissue and cell can strengthen aging course.ROS and polyphenoils in human body
Protective effect between unbalance can cause aging [Halliwell B:Oxidative stress and cancer:have
We moved forward Biochem.J 2007,401:1-11.];[Duracková Z:Some current insights
Into oxidative stress.Physiol.Res.2010,59:459-469].Oleuropein is absorbed and neutralized by it
The antioxidation delaying sanility process of ROS materials.
High biological is available.The antioxidant that target tissue and organ can not be reached with sufficient amount will not be brought to the mankind as
The benefit that compound as OL can reach, it has already been proven that OL is high biological available [Cicerale S, Lucas
LJ, Keast RS:Antimicrobial, antioxidant and anti-inflammatoryphenolic
Activities in extra virgin olive oil.Curr.Opin.Biotechnol.2012,23:129-135.];
[Cicerale S, Lucas L, Keast R:Biological activities of phenolic
Compoundspresent in virgin olive oil.Int.J Mol.Sci.2010,11:458-479.].
The main mechanism of OL effects includes:1) free radical scavenger and free radical chain fracture;2) resisting oxidation free radical;With 3)
Metal-chelator.
OL catechol structure makes them remove peroxy radical and break peroxidating chain reaction to produce stabilization
Resonant structure [Tripoli E, Giammanco M, Tabacchi G, DiMajo D, Giammanco S, La Guardia M:
The phenolic compounds of olive oil:Structure, biological activity
Andbeneficial effects on human health.Nutr Res Rev 2005,18:98-112.];[Bulotta
S, Oliverio M, Russo D, Procopio A:Biological Activity ofOleuropein and its
Derivatives.In Natural Products.Edited by Ramawat KG, M é rillon JM.Berlin:
Heidelberg Springer-Verlag;2013:3605-3638.].
Angiocardiopathy (CVD).OL antiphlogistic effects are known.CVD and chronic states body inflammation height correlation,
Wherein body inflammation is caused by several factors, such as heredity, obesity, diabetes, smoking, exogenous pollution, diet, do not move and
Other factorses.
OL can help to promote circulation by vasorelaxation action, reduce the influence of CVD results.It is anti-oxidant.Antiplatelet
Aggregation.Thrombus in important blood vessels (such as the coronary artery and arteria carotis and cerebral artery of heart) causes poisonous and is typically to cause
The cardiovascular event of life, such as miocardial infarction (heart disease) and apoplexy.OL resistant to aggregation effect helps to prevent such event..
Ldl cholesterol oxidation.LDL-C (LDL-C) is typically considered " bad " courage
Sterol, because its internal arterial wall (endothelium) causes Atherosclerosis (blood platelet generation).However, working as LDL-
C is after peroxidating, and their effect is significantly enhanced, and wherein LDL-C oxidation is adjusted in human body by copper sulphate abduction mechanism
Section.Oleuropein slows down the circulatory diseases process by its scavenging action to HOCl, and HOCl is anti-in LDL-C lipid peroxidations
Effect [Carr AC, Tijerina T, the Frei B of initiator is played during answering:Vitamin C protects against
and reverses specifichypochlorous acid-and chloramine-dependent modifications
Of low-density lipoprotein.Biochem.J 2000,346:491-499.].Thus, removings of the OL to HOCl is made
With to lipoid peroxidization resistant and LDL-C oxidation can be reduced, the atherosclerosis disease of arterial endothelium is caused to deteriorate drop
It is low, so as to reduce the risk of angiocardiopathy and cardiovascular event (such as miocardial infarction and apoplexy).
Pipering (Piperine)
Pipering (black pepper piper longum (piper longum) extract) is a kind of bioavilability reinforcing agent.Bioaugnentation
Agent has the physiologic effect for improving the concentration that the nutraceutical applied is organized in target end organ.For example, once containing required chemical combination
The material of thing is ingested, and bio-enhancer can improve the amount or target organ concentration of compound.The concentration of this raising has to health
Profit, because bioactivity of the compound of intake in target end organ organizes is extended or strengthened.
A kind of main favorable property of pipering is that it can suppress the enzyme drug biotransformation reaction in liver.Pepper
Alkali being capable of strong inhibition liver sausage aryl hydrocarbon-hydroxylase and UDP-glucoronosyl/transferase.The result of reduction liver and intestines degraded is Chinese mugwort
The more multi cycle of leaf extract and OL, so as to bring more required positive health effects.
The Bioaugnentation effect of pipering is also attributed to the enhancing of intestinal absorption to a certain extent, and this is that pipering is acted on
The result of the ultra microstructure of microvillus on intestinal brush border.Enhanced absorption improves concentration of the nutriment compound in serum,
So that its bioavilability for receiving blood circulation and perfused tissue to tissue is bigger.
Although current research indicates folium artemisiae argyi and oleuropein has anti-inflammatory and antioxidant properties, pipering is biological profit
Expenditure reinforcing agent, the present inventor by research it has unexpectedly been discovered that, when above-mentioned substance is according to special ratios carry out group
Anti-inflammatory and antioxidant properties are significantly increased during conjunction.
Specifically, according to an aspect of the present invention, the invention provides a kind of dietary supplements, count by weight,
The dietary supplements includes:60-80 parts of Folium Artemisiae Argyi extracts, 10-20 parts of oleuropeins and 10-20 parts of piperings;Preferably, originally
The dietary supplements of invention includes:65-75 parts of Folium Artemisiae Argyi extracts, 12-18 parts of oleuropeins and 12-18 parts of piperings;More preferably
Ground, dietary supplements of the invention includes:70 parts of Folium Artemisiae Argyi extracts, 15 parts of oleuropeins and 15 parts of piperings.
The present inventor by research it has unexpectedly been discovered that, when Folium Artemisiae Argyi extract, oleuropein and pipering are pressed
When being combined according to ratio of the invention, cooperated between three, with synergy.
On the one hand, their own advantage is passed through into the prevention from suffering from the diseases of offer height on the basis of subassembly at these three
And the anti-oxidation characteristics after combination, reduce or eliminate chronic body inflammation and oxidative stress, the internal free radical of reduction and activity
The concentration of oxygen (ROS);These three anti-oxidant and anti-inflammatory components act on the mankind and animal body specific to prevent by be combineding with each other
Disease, this ability is further enhanced by pipering, and pipering can take in the intestines of nutrient for plants compound by increasing
Road absorbs, and by reducing its internal metabolism elimination in liver and intestinal wall, and then increase the nutrient for plants of its intake
The bioavilability of compound.
Particularly, in terms of pre- anti-cancer, such as colon cancer and many other alimentary tract cancers and other body parts
The cancer of presence, dietary supplements of the invention is highly effective.Oleuropein is anticancer phenolic compound, it was verified that olive
Bitter glycosides suppresses several mechanism of growth of cancer cells.Similar to folium artemisiae argyi, oleuropein is bred to cancer also has inhibition.The chemical combination
Thing spreads to cancer cell also has direct inhibition.In the dietary supplements of the present invention, Folium Artemisiae Argyi extract and olive are bitter
Glycosides combines the permanent anticancer effect obtained and further strengthened by pipering.Specifically, dietary supplements of the invention is not any
Side effect, the combination of two kinds of naturally occurring phytochemicals can suppress the painstaking effort of growth of cancer cells and the induction of pre- anti-cancer
Pipe is formed, so as to flow to the blood flow of cancer cell, these effects further can be strengthened by the Bioaugnentation effect of pipering, so that
The high-efficient pure natural nutrient for plants replenishers of the pre- anti-cancer of the present invention are obtained.
On the other hand, when Folium Artemisiae Argyi extract, oleuropein and pipering are combined according to aforementioned proportion, by with olive
Olive hardship glycosides and Folium Artemisiae Argyi extract bioactivity plant nutrient synergy, the positive health effect of pipering have also obtained pole
Big raising and amplification.These effects include:Anti-inflammatory, anti-oxidant, anti-rotation shifting, antibacterial, anti-mutation and antitumor and anti-wither
Die, these effects are the pipering other properties healthy and beneficial to humans and animals, and in oleuropein and Folium Artemisiae Argyi extract
These effects of the lower pipering of effect have obtained enhancing and further activation.Except play bioperformance enhancing agent function it
Outside, by suppressing and being quenched free free radical and reactive oxygen species, and by reducing peroxidatic reaction of lipid and positive shadow
Intracellular mercaptan state, antioxidant molecule and antioxidase are rung, pipering is also prevented from oxidative stress associated tissue damage.
Folium Artemisiae Argyi extract, oleuropein and pipering are not combined according to the ratio of the present invention, three's synergy, and not
The replenishers matched using the present invention are compared, and the anti-oxidant and antiphlogistic effects of dietary supplements of the invention are not only significantly carried
Height, and effect is lasting.Compared with only taking any one or two kinds in Folium Artemisiae Argyi extract, oleuropein and pipering, or
Person, compared with not using the replenishers that the present invention is matched, the antioxidant effect of dietary supplements of the invention is significantly higher than three kinds
The independent effect sum of component.It is a kind of systematically measure and compare food and the method for the oxidation resistance of replenishers be measurement oxygen from
By base absorbability (ORAC).The ORAC of oleuropein is 12,000 TE/ grams of micromole, and the ORAC of Folium Artemisiae Argyi extract is 57-112
TE/ grams of micromole, the ORAC of pipering is very small and is comparatively speaking insignificant, therefore the ORAC of oleuropein compares folium artemisiae argyi
Extract is big 100 times.And for the dietary supplements of the present invention, its effect effect sum more independent than each component is big at least
50-100%.
The main component of Folium Artemisiae Argyi extract is anti-oxidant polyphenol, flavonoids and carotenoid compounds, and cumarin,
Glucosides, polyacetylene, monoterpene, sterol, triterpene, sesquiterpene, eudesmane, polyunsaturated fatty acid, vitamin C, essential amino acid
And essential oil.
Folium Artemisiae Argyi extract can extract from the whole aerial part of folium artemisiae argyi plant, including leaf and stalk.Preferably, use
Supercritical CO2Abstraction technique and/or moisture film extract filtering technique to obtain Folium Artemisiae Argyi extract.Both extractive techniques avoid using
Ethanol, methanol or other any chemical reagent.Moisture film extraction filtering technique only uses water as solvent, and supercritical CO2Extraction
Technology is taken (for example, using high pressure (100-150 bars) and the supercritical CO of low temperature (40 degrees Celsius)2Abstraction technique) it is in high-pressure section
Lower of part uses the carbon dioxide being perfectly safe.Moisture film extracts filtering technique while avoiding using chemical solvent, makes folium artemisiae argyi
Extract has reached that total phenolic compound (polyphenol) and flavonoids (other bioactivity beneficial compounds) have highest concentration.
The antioxidation activity for the Folium Artemisiae Argyi extract being obtained by extraction by water is than other solvents such as methanol, acetone, ethanol and chloroform extraction
The activity gone out is high.Supercritical CO is preferred in order to obtain the extract in optimal anti-inflammatory bioactivity, folium artemisiae argyi flower2Extract
Technique productions.Therefore, the present invention extracts the extract and supercritical CO of filtering technique using moisture film2The extract institute of abstraction technique
The composition of composition is come the phenols of realizing highest level is anti-oxidant and anti-inflammatory bioactivity.
In a kind of preferred embodiment, folium artemisiae argyi extraction process includes following workshop section:
1. the plant material collection stage
Before the extraction stage, first the folium artemisiae argyi plant material of harvest is screened, is cleaned, sterilized and ground, to give birth to
Produce the biological active component of final products.
The stalk of the leaf of plant and aerial part is transported into extraction factory first and carries out cleaning and plant part sorting.
In order that the yield of anti-oxidant phenolic resin, flavonoids, carotenoid Phytochemistry compound is maximum, it is necessary to make whole
Plant material selection and processing process system.This will need following device:
(1) it is used for the conveyer belt and system for collecting plant material
(2) disleave and vibratory sieve separation device, to screen a variety of plant positions
(3) washing and sorting line, for cleaning and screening vegetable matter
2. the plant material primary treatment stage
Folium artemisiae argyi plant material must mechanically and chemically be handled to maximize the extraction of bioactive compound.
Mainly extracted to avoid using organic solvent using distilled water.Use isolation technics, particularly film skill
Art, to carry out flooding and purifying process.These technologies include ultrafiltration, filter, dialysis and electrodialysis successively.
Water soluble active component is extracted in hot water of the temperature less than 80 DEG C, such as anti-oxidant phenolic aldehyde, flavonoids and class are recklessly
Radish extract plant chemical compound.Using supercritical CO2Abstraction technique extracts other hydrophobic substances, such as saturation and insatiable hunger
The aliphatic acid of sum.
The bioactivity vegetalization material extracted from folium artemisiae argyi has variable hydrophobicity and a partial hydrophilicity, therefore can be with
Using supercritical CO2Abstraction technique and water film filtering technology extract these materials.Characterization of The Products is extracted come closely using analysis
Monitoring optimization is extracted.The standard of Such analysis includes:Uniformity, heat endurance, humidity, fragrance, freezing point, electric conductivity, pH and
Gelling ability.
Carefully the formulation of concern final products is to produce various pulvis, tablet, capsule and liquid extract, and this is very
Important.
In a word, the folium artemisiae argyi extraction equipment needed for above-mentioned technique is as follows:
(1) plant grinding device, including industrial grinding mills and plant and seed shredding machine.
(2) supercritical fluid CO2Extraction equipment, is extracted for hydrophobic plant chemical compound.
(3) solvent extraction system.This is directed to use with extracting for water-soluble substances or the water or ethanol of non-water soluble substance
Device.
(4) the thick system for carrying, collecting and storing for folium artemisiae argyi, by stainless cylinder of steel and copper pipe of reservoir group into.
(5) system in extraction process needed for bulk liquids transhipment, is made up of pump and pipeline.
3. separation and enriching stage
Crude extract (including water and alcoholic solution) must be refined by using the isolation technics of filtering and Distallation systm.
Then, obtained fraction is further concentrated by evaporating, to obtain the bioactive substance of higher concentration.
Further improve the concentration of purified extract using membrane technology, the membrane technology is nanofiltration, counter-infiltration, it is dense to freeze
Contracting, vacuum evaporation.
The equipment in these stages includes:Membrane filtration system, stainless cylinder of steel and reservoir system for collecting liquid in the middle of liquid,
Pump and pipe-line system for transporting liquid, concentration and drainage equipment:Vacuum, fluid bed and thin film evaporator.
4. refining stage
Then, the liquid fraction of the concentration obtained to separation and concentration process further carries out refining operation, to incite somebody to action
Specific compound (polyphenol and flavonoids) is separated with other materials (salt, sugar and protein).This effectively increases bioactivity
The yield and purity of compound.Further, it is necessary to convert liquids to stable formulation such as powder, and therefore need to dry system
System.
Equipment:
(1) chromatographic system, it is equipped with the industrial columns of ion-exchange chromatography
(2) drying system:Fluidized bed drying system, spray drying system, freeze-drier
The present invention dietary supplements in, the oleuropein extract from olive fruits, olive leaf, olive plant chimney stalk,
Olive water extract and/or olive oil, it is preferred to use moisture film technology (i.e. moisture film extraction filtering technique or water film filtering technology).Use
Water is used as unique solvent, it is to avoid use chemical substance, and the antioxidation activity of maximum can be realized by water film filtering technology.Film mistake
Filter technology is including the use of ultrafiltration, filter, dialysis and electrodialysis.The concentration of purified extract can in the steps below be entered using membrane technology
OK:Nanofiltration, counter-infiltration, freeze concentration and vacuum evaporation.
There are many methods can be for extracting pipering from black pepper.It should be noted that start extraction process it
Before, it is necessary to first black pepper is ground using industrial grinding mills.
Pipering can use dichloromethane to extract.Using aqueous cosolvent, it can bring high yield and high selectivity.
Another conventional method be using potassium hydroxide solution handle the solvent-free residue from black pepper ethanol extract so as to
Remove the insoluble residue washed in resin and warm ethanol.Alkaloid is crystallized during this by cooling down.This is directed to use with
Water and ethanol extractor for water-soluble substances.
Discounting for cost issues, supercritical CO is preferably used under elevated pressure conditions2Abstraction technique come extract recklessly
Green pepper alkali, because this method is only using harmless and overall safety carbon dioxide and to bring high-purity, high yield under high pressure
The pipering of amount.
In addition to the above-mentioned content referred to, the other specific process parameters and condition being related in the above method are this area skills
Art personnel can determine that the appropriate adjustment of process conditions will not be to extract in meals of the invention according to needs of production
Effect played in replenishers produces materially affect.
The dietary supplements of the present invention can adopt the Folium Artemisiae Argyi extract, oleuropein and pipering of extraction according to aforementioned proportion
Formed with conventional method is well mixed.
The dietary supplements of the present invention can further comprise that dietetic product is upper and/or pharmaceutically acceptable carrier with/
Or auxiliary material, for example, filler, disintegrant, lubricant, suspending agent, adhesive, sweetener, flavouring, preservative etc..Filler
Including:Starch, pregelatinized starch, lactose, mannitol, chitin, microcrystalline cellulose, sucrose etc..Disintegrant includes:Carboxymethyl forms sediment
Powder sodium, PVPP, low-substituted hydroxypropyl cellulose, Ac-Di-Sol etc..Lubricant includes:It is stearic
Sour magnesium, lauryl sodium sulfate, talcum powder, silica etc..Suspending agent includes:Polyvinylpyrrolidone, microcrystalline cellulose, sugarcane
Sugar, agar, hydroxypropyl methyl cellulose etc., adhesive includes, starch slurry, polyvinylpyrrolidone, hydroxypropyl methyl cellulose
Deng.Sweetener includes:Saccharin sodium, aspartame, sucrose, honey element, enoxolone etc..Flavouring includes:Sweetener and various
Essence, preservative includes:Parabens, benzoic acid, sodium benzoate, sorbic acid and its esters, benzalkonium bromide, chlorhexidine acetate,
Eucalyptus oil etc..By adding corresponding carrier and/or auxiliary material, oral agents can be further made in dietary supplements of the invention
Type, for example, powder, tablet, capsule, granule, oral liquid or pill etc..In actual production, those skilled in the art can
The consumption of carrier and auxiliary material is determined according to actual needs, to reach optimal using effect.
When preparing final dietary supplement product, it is necessary to which the production system of such as tablet and capsule, what is be related to is specific
Equipment is to prepare the powder compressibility needed for capsule and tablet.In addition, when preparing final dietary supplement product, also relating to
And packing stage, i.e., final products are packed with solid dosage forms or liquid dosage form, be primarily related to be used for encapsulating products
Blister packaging equipment and bottling line for fluid product.
Take in the restriction of application
According to another aspect of the present invention, it is turned into the invention provides foregoing dietary supplements in preparation with antioxygen
Application in health products or medicine.
According to another aspect of the present invention, prepared the invention provides foregoing dietary supplements with antiinflammatory action
Health products or medicine in application.
According to another aspect of the present invention, preparing prevention the invention provides foregoing dietary supplements and/or controlling
Treat the application in the health products or medicine of any one or more following disease:Oxidative stress, chronic inflammation, angiocardiopathy
(CVD), artery sclerosis, cancer, Arterial Hypertention, diabetes, caused by hypercholesterolemia and similar relevant disease, cigarette
Oxidative stress and tissue damage, age-related body aging, overweight and fat, bacterium sense caused by Health cost, pollution
Loss and motion loss that dye, nerve degenerative diseases, skin symptom, ultraviolet trigger.
Specifically, dietary supplements of the invention has significant prevention and/or therapeutic effect to following disease or symptom:
1. angiocardiopathy, for example, apoplexy, myocardial infarction and artery sclerosis.The dietary supplements of the present invention is by reducing
Inflammation reduces the risk of angiocardiopathy with anti-oxidant feature is improved, and can reduce the ability of blood formation thrombus grumeleuse,
So as to reduce the ability of their blocked coronary arteries and arteria carotis inner chamber.
2. cancer, such as breast cancer, colon cancer, prostate cancer, cancer of pancreas, lung cancer, and some other tumours.This hair
Bright dietary supplements can suppress growth of cancer cells or directly kill cancer cell, and effectively suppress cancer blood circulation.In addition, this
The chemical signal of generation blood vessel of the dietary supplements of invention to being sent by cancer cell, which has, directly suppresses anti-angiogenesis work
With so that causing the survival rate of the cancer cell contacted with dietary supplements of the invention reduces.
The research of inventor also has confirmed another mechanism of pre- anti-cancer, and it is based on passing through CNR1 promoters site
The change of DNA methylation carrys out transient state up-regulation CNR1 tumor suppressor genes.
3. diabetes.The research of inventor shows, periodically takes the diabetic of the dietary supplements of the present invention, display
Its fasting blood glucose level and the reduction of glycated hemoglobin (HbA1c) level.These results show the dietary supplements of the present invention to sugar
Urine patient has positive effect.
Wherein, HbA1c is the subgroup for circulating red blood cell (red blood cell), and in diabetes and pre-diabetic, it contains
Amount is higher than normal range (NR) (4-5.6%), and this is attributed to the irreversible glycosylation in corpuscular hemoglobin β chain N- ends.Scope is
5.7-6.4% HbA1c high value is consistent with pre-diabetes condition, so as to add the risk for suffering from diabetes.6.5% or
Higher level is consistent with the diagnosis to diabetes.The dietary supplements of the present invention can reduce diabetes and prediabetes is suffered from
The HbA1c levels of person.
4. cholesterol, particularly serum cholesterol.The dietary supplements of the present invention is to reduction serum low-density LP
(LDL-C) has remarkable effect.
In addition, the dietary supplements of the present invention can cause the aobvious of the serum-concentration of OxLDL ELISA (ox-LDL)
Writing reduction and the referred to as inflammation blood plasma biomarker of plasma C-reactive protein (CRP) significantly reduces.LDL-C pairs of oxidation
The harm of cardiovascular health is bigger, because the LDL-C of oxidation produces artery, (particularly heart and arteria carotis is coronal dynamic
Arteries and veins) fat lesion atherosclerotic plaque ability it is stronger.
In addition, the present invention dietary supplements can increase the serum levels of HDL (HDL cholesterol), this
It is beneficial in terms of reducing the health risk for suffering from artery sclerosis.The research of inventor also shows that the dietary supplements of the present invention is improved
HDL cholesterol efflux abilities, this can improve the healthy curve of user by improving the physiological function of body, so that clearly
Manage the artery influenceed by atherosclerosis.
5. hypertension.Research in laboratory scope shows that dietary supplements of the invention significantly reduces systolic pressure
And diastolic pressure.
Inventor also found that dietary supplements of the invention is significant to reduce blood pressure and improve with slight high by research
The endothelial function of the young woman of blood pressure.Due to, it is known that the lifting in treatment hyperpietic of the function of arterial wall endothelial cell
Act on, therefore endothelial function is extremely important in the elevated patient of blood pressure.Inner skin cell function is better, and blood pressure is more normal.
6. extend the life-span.The zoopery that inventor is carried out shows, the dietary supplements of the present invention is periodically taken in daily
The life-span of the control group adult mice of dietary supplements of the life-span of adult mice than not taking in the present invention is extended.Herein
In the positive health effect expection enumerated people can be produced similar prolong long-life effect.
The research of inventor is it is also shown that the dietary supplements of the present invention can slow down cell ageing by some physiological phenomenons
Process.The present invention dietary supplements can energetically resist epigenetics (such as DNA methylation) change, telomere cut down,
Protein homeostasis is lost and nutrition senses imbalance.The present invention dietary supplements can also prevent mitochondria dysfunction and
Stem cell is exhausted and cell ageing.The dietary supplements of the present invention can prevent the oxidative damage to inhereditary material, so as to promote
Enter genome stable.
7. smoking.It is well known that one of harmful mechanism of harmfulness of smoking health is drawn with main and secondary smoking
The body inflammation-related risen.This inflammation causes various disease-angiocardiopathies and cancer to be most common two kinds.
Daily ingestion of dietary supplements of the invention helps to protect human body from harm of smoking.Its mechanism of action is:
1) prevents oxidative stress caused by smoke from cigarette, 2) prevents caused by nicotine the damage of lung's antioxidase and increased lipid
Peroxidation, 3) prevents the inflammation damnification that is directly contacted between smoke from cigarette and bronchial wall tissue, 4) prevents nicotine
Angiogenesispromoting effect, suppress the growth of tumour and cancer.
8. air pollution.Similar to smoke from cigarette, air pollution can cause oxidative stress, reduce body antioxidase, and
And be proinflammatory disease.The dietary supplements of the present invention can protect the body from free radical and aoxidize to answer because of its anti-oxidation characteristics
Swash.This protection is then also possible to prevent the sequelae of oxidative stress and air pollution, such as COPD and cancer.
9. skin protection.It is harmful to skin health exposed to ultraviolet (UV) radiation.Ultraviolet can be with the bottom of injured skin
Layer scaffolding protein (being referred to as collagen and elastin laminin) suppresses skin corium fibroblast metabolism and produces collagen and bullet
Property albumen, and produce also cause dermal tissue insult free radical.
The dietary supplements of the present invention helps to protect skin by eliminating skin free radical, so as to limit the group of correlation
Knit damage.In addition, the dietary supplements of the present invention also enhances the generation of glutathione, this also contributes to protect the skin from certainly
By the injury of base.
The dietary supplements of the present invention has direct inhibitory action to cancer cell, so as to contribute to the skin of protection exposure
The cutaneum carcinoma induced from UV, the invasion and attack of such as melanoma.
10. arthritis.Arthritis be it is a kind of influence body joints inflammatory disease, including backbone, buttocks, knee, shoulder,
Ancon, ankle, wrist, pin and pin.Soft tissue inflammation and cartilage inflammation of the dietary supplements of the present invention to arthritis and correlation
With direct effect.
11. body weight.The present inventor is by studying discovery, the increasing that dietary supplements of the invention can lose weight
Plus, so as to effectively prevent and treat obesity.
12. skin whitening.The dietary supplements of the present invention can directly reduce melanocyte activity and increase gluathione
The generation in vivo of peptide, so as to be conducive to skin whitening.
13. mental health.The dietary supplements of the present invention is by promoting elimination intracerebral amyloid-beta to provide god
Through protection, so that the prevention and treatment for nerve degenerative diseases such as alzheimer disease (AD) etc..
14. infection.Experiment in vitro proves that dietary supplements of the invention has the property of antibacterial, therefore the meals of the present invention
Eating replenishers can be as the antiseptic applied to prevention enteron aisle and respiratory tract infection.
15. gene clock (Gene Clock).According to the research of inventor, clock Physiological effect base is had been reported that now
Because (clock circadian regulator gene) CLOCK CpGs 1 and 8 ratios methylated are shown and single unsaturation
Aliphatic acid (MUFA) [Milagro, F.I.et al.Clock, PER2and relevant with the intake of polyunsaturated fatty acid (PUFA)
BMAL1 DNA methylation:Association with obesity and metabolic syndrome
Characteristics and monounsaturated fat intake.Chronobiol.Int.2012,29,1180-
1194.].Once such material containing MUFA is Extra Virgin, it is also enriched in aldehydes matter, such as oleuropein,
So oleuropein component of the invention has good effect for up-regulation Clock genes and BMAL1 gene activities.CLOCK bases
Because (clock gene) is responsible for the biological clock rhythm system of body, 24 circadian rhythm 24s of the systematic direction gene expression in itself.
The gene is relevant with fat and metabolic syndrome.Researcher has been found that patient and trouble with visceratonia abdominal fat obesity
The patient for having metabolic syndrome shows the symptom (timer interrupt) of circadian rhythm disorders, and the illness can produce larger body weight
Increase and then fat tendency, further development can cause diabetes and atherosclerosis [G ó mez-Santos, C.et
Al.Circadian rhythm of clock genes in human adipose explants.Obesity 2009,17,
1481-1485].The dietary supplements of the present invention can regulate and control CLOCK gene activation approach, so as to help to prevent and reduction is made
Factor in terms of the fat gene with metabolic syndrome.
Causality [Yoshino J, Klein S is also likely to be present between the suppression of CLOCK genes and diabetes B
(Jul 2013).″A Novel Link Between Circadian Clocks and Adipose Tissue Energy
Metabolism″.Diabetes.62(7):2175-7].Therefore, the regulation and control to CLOCK genes help to prevent or reduce by 2 types
The seriousness of diabetes.
The research of inventor displays that the epigenetic variation of CLOCK genes is relevant with breast cancer incidence raising, and this is
Because the reduction that methylates of the CLOCK promoter regions of the women suffered from breast cancer.The dietary supplements of the present invention being capable of actively impact
These are mutated and reduce their influences to CLOCK genes, so as to reduce the risk suffered from breast cancer.
The research of inventor is displayed that, causes have height between the somatic mutation of colorectal cancer and CLOCK mutation
Correlation.The dietary supplements of the present invention helps to stablize CLOCK genes to prevent CLOCK to be mutated, so as to contribute to pre-
CLOCK is mutated in the anti-microsatellite instability target gene for causing colorectal cancer.
Effect of the dietary supplements of the present invention on CLOCK gene expressions can also influence circadian rhythm period, thus regulation and control
Sleep pattern.CLOCK and CYCLE albumen (circulating protein) (dBMAL genes) can form dimer, the compound finally with
Period (per, Per1 gene) and timeless (tim genes) promoter combine to raise (stimulation) per genes and tim
Gene.Therefore, dietary supplements of the invention is the adjusting control agent of CLOCK genes.The regulation activity can treat and prevent sleep
Rhythm disorder, and the associated disorders caused by being travelled in multiple time zones, the i.e. time difference can be treated and prevented.
Embodiment
The present invention is further illustrated below by the mode of embodiment, but does not therefore limit the present invention to described reality
Apply among a scope.The experimental method of unreceipted actual conditions in the following example, conventionally and condition, or according to business
Product specification is selected.
The Folium Artemisiae Argyi extract used in following embodiments is divided into raw material using overcritical with the whole overground part of folium artemisiae argyi plant
CO2Abstraction technique is obtained.Oleuropein is obtained by raw material of olive fruits using moisture film technology.Pipering is using black pepper as raw material
Using supercritical CO2Abstraction technique is obtained.Wherein, supercritical CO2Condition in abstraction technique and moisture film technology is normal condition.
Embodiment 1
The composition of the dietary supplements of embodiment 1 is Folium Artemisiae Argyi extract 70mg, oleuropein 15mg and pipering 15mg.
Preparation method:
Folium Artemisiae Argyi extract 70mg, oleuropein 15mg and pipering 15mg are well mixed, the meals for producing embodiment 1 are mended
Fill agent.
Embodiment 2
The composition of the dietary supplements of embodiment 2 is Folium Artemisiae Argyi extract 60mg, oleuropein 20mg and pipering 20mg.
Preparation method:
Folium Artemisiae Argyi extract 60mg, oleuropein 20mg and pipering 20mg are well mixed, the meals for producing embodiment 2 are mended
Fill agent.
Embodiment 3
The composition of the dietary supplements of embodiment 3 is Folium Artemisiae Argyi extract 80mg, oleuropein 10mg and pipering 10mg.
Preparation method:
Folium Artemisiae Argyi extract 80mg, oleuropein 10mg and pipering 10mg are well mixed, the meals for producing embodiment 3 are mended
Fill agent.
Embodiment 4
The composition of the dietary supplements of embodiment 4 is Folium Artemisiae Argyi extract 65mg, oleuropein 18mg and pipering 17mg.
Preparation method:
Folium Artemisiae Argyi extract 65mg, oleuropein 18mg and pipering 17mg are well mixed, the meals for producing embodiment 4 are mended
Fill agent.
Embodiment 5
The composition of the dietary supplements of embodiment 5 is Folium Artemisiae Argyi extract 75mg, oleuropein 12mg and pipering 13mg.
Preparation method:
Folium Artemisiae Argyi extract 75mg, oleuropein 12mg and pipering 13mg are well mixed, the meals for producing embodiment 5 are mended
Fill agent.
Embodiment 6
The composition of the dietary supplements of embodiment 6 is Folium Artemisiae Argyi extract 65mg, oleuropein 17mg and pipering 18mg.
Preparation method:
Folium Artemisiae Argyi extract 65mg, oleuropein 17mg and pipering 18mg are well mixed, the meals for producing embodiment 6 are mended
Fill agent.
Embodiment 7:Oral liquid
The dietary supplement product of embodiment 7 is oral liquid, and the capacity of every oral liquid is 15ml, including:Folium artemisiae argyi is extracted
Thing 70mg, oleuropein 15mg and pipering 15mg, sucrose 20mg, and water 15ml.
Preparation method:By Folium Artemisiae Argyi extract 70mg, oleuropein 15mg and pipering 15mg, sucrose 20mg is dissolved in 15ml water
In, it is well mixed;Homogenization is then carried out in homogenizer, various nutritional ingredients is homogenized, obtains the stability of product
To further guarantee;Then carry out filling, produce the oral liquid of embodiment 7.
Embodiment 8:Granule
The dietary supplement product of embodiment 8 is granule, including:Folium Artemisiae Argyi extract 70mg, oleuropein 15mg, 15mg
Pipering, sucrose 10mg and starch slurry 20mg.
Preparation method:After all materials are mixed 4 minutes, the water of material gross weight 3% is uniformly poured into, is stirred 1 minute;
Then, granulated using 1 millimeter of screen cloth rotary squeezing of diameter;Then, 105 DEG C of dryings 4 minutes;Finally, 20 DEG C cool down 1 point, and cross 2
Mm sieve, is produced.
Above-described embodiment is the present invention preferably embodiment, but present aspect embodiment not by above-described embodiment
Limitation, other any Spirit Essences without departing from the present invention and the replacement made under principle, modification, combine, change, simplification
Deng should be equivalent substitute mode, be included within protection scope of the present invention.Protection scope of the present invention should be with right
What claim was limited is defined.
Claims (14)
1. a kind of dietary supplements, it is characterised in that count by weight, the dietary supplements includes:60-80 portions of folium artemisiae argyis are carried
Take thing, 10-20 part oleuropein and 10-20 parts of piperings.
2. dietary supplements according to claim 1, it is characterised in that count by weight, the dietary supplements bag
Include:65-75 parts of Folium Artemisiae Argyi extracts, 12-18 parts of oleuropeins and 12-18 parts of piperings.
3. dietary supplements according to claim 1 or 2, it is characterised in that count by weight, the dietary supplements
Including:70 parts of Folium Artemisiae Argyi extracts, 15 parts of oleuropeins and 15 parts of piperings.
4. the dietary supplements according to claim any one of 1-3, it is characterised in that the Folium Artemisiae Argyi extract extracts from Chinese mugwort
The whole aerial part of leaf plant.
5. the dietary supplements according to claim any one of 1-4, it is characterised in that the oleuropein extracts from olive
Fruit, olive water extract and/or olive oil.
6. the dietary supplements according to claim any one of 1-5, it is characterised in that the dietary supplements is further wrapped
Include in dietetic product and/or pharmaceutically acceptable carrier and/or auxiliary material.
7. the dietary supplements according to claim any one of 1-6, it is characterised in that the dietary supplements is made into mouth
Oral dosage form;Preferably, the peroral dosage form is powder, tablet, capsule, granule, oral liquid or pill.
8. the preparation method of the dietary supplements described in claim any one of 1-7, it is characterised in that the preparation method bag
Include:Prepare Folium Artemisiae Argyi extract, oleuropein and pipering according to predetermined ratio;And by Folium Artemisiae Argyi extract, oleuropein and Hu
Green pepper alkali is mixed.
9. preparation method according to claim 8, it is characterised in that the Folium Artemisiae Argyi extract uses supercritical CO2Extract skill
Art and/or moisture film extraction filtering technique are prepared.
10. preparation method according to claim 8 or claim 9, it is characterised in that the oleuropein extracts filtering using moisture film
Technology is prepared.
11. the preparation method according to claim any one of 8-10, it is characterised in that the pipering uses supercritical CO2
Abstraction technique is prepared.
12. the dietary supplements described in claim any one of 1-7 is in the health products or medicine with antioxidation are prepared
Application.
13. the dietary supplements described in claim any one of 1-7 is in the health products or medicine with antiinflammatory action are prepared
Using.
14. dietary supplements described in claim any one of 1-7 prepare prevention and/or treat it is following any one or more
Application in the health products or medicine of disease or symptom:Oxidative stress, chronic inflammation, angiocardiopathy (CVD), artery sclerosis,
Cancer, Arterial Hypertention, diabetes, Health cost, pollution caused by hypercholesterolemia and similar relevant disease, cigarette are drawn
The oxidative stress and tissue damage, age-related body aging, overweight and fat, bacterium infection, nervus retrogression disease risen
Loss and motion loss that disease, skin symptom, ultraviolet trigger.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710535181.1A CN107280008A (en) | 2017-07-03 | 2017-07-03 | A kind of dietary supplements and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710535181.1A CN107280008A (en) | 2017-07-03 | 2017-07-03 | A kind of dietary supplements and its preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107280008A true CN107280008A (en) | 2017-10-24 |
Family
ID=60099218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710535181.1A Pending CN107280008A (en) | 2017-07-03 | 2017-07-03 | A kind of dietary supplements and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107280008A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103655731A (en) * | 2013-12-11 | 2014-03-26 | 张宗升 | Natural pharmaceutical composition |
US20140227198A1 (en) * | 2013-02-13 | 2014-08-14 | GRADS Holdings LLLP | Shelf-stable olive extract-containing compositions and methods of use thereof |
CN104623553A (en) * | 2015-02-12 | 2015-05-20 | 王彦 | Traditional Chinese medicine composition for treating annexitis |
CN104800597A (en) * | 2015-05-23 | 2015-07-29 | 周末 | Traditional Chinese medicine composition for treating sphagitis |
CN106174205A (en) * | 2016-07-26 | 2016-12-07 | 厦门益力康生物科技有限公司 | A kind of fruit ferment and preparation method thereof |
-
2017
- 2017-07-03 CN CN201710535181.1A patent/CN107280008A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140227198A1 (en) * | 2013-02-13 | 2014-08-14 | GRADS Holdings LLLP | Shelf-stable olive extract-containing compositions and methods of use thereof |
CN103655731A (en) * | 2013-12-11 | 2014-03-26 | 张宗升 | Natural pharmaceutical composition |
CN104623553A (en) * | 2015-02-12 | 2015-05-20 | 王彦 | Traditional Chinese medicine composition for treating annexitis |
CN104800597A (en) * | 2015-05-23 | 2015-07-29 | 周末 | Traditional Chinese medicine composition for treating sphagitis |
CN106174205A (en) * | 2016-07-26 | 2016-12-07 | 厦门益力康生物科技有限公司 | A kind of fruit ferment and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101674821B (en) | Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid | |
CA2520207C (en) | Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease | |
CN102872306B (en) | Compound selenium Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
JP2009126853A (en) | Therapeutic agent | |
JP4686173B2 (en) | Processed acerola containing polyphenol and / or vitamin C | |
CN101766274B (en) | Antioxidant functional food composition containing bamboo-leaves flavones | |
KR20120003693A (en) | Anti-obesity composition comprising red grape extracts, green tea extracts, soybean extracts, and l-carnitine | |
KR100976241B1 (en) | Extract of sedum sarmentosum for alcohol oxidation and relieves hangover | |
WO2005087246A1 (en) | Antitumor agent | |
WO2006090206A1 (en) | Improved extracts of psidium guajava l., methods for its obtaining and use for the treatment of gastrointestinal disorders | |
CN107456505A (en) | A kind of dietary supplements and its preparation method and application | |
KR101821925B1 (en) | A composition comprising the complex extract of Poncirus trifoliata and Cinnamommum cassia for treating or preventing allergy desmatitis | |
JP2018506524A (en) | Composition for prevention, amelioration or treatment of burnout syndrome | |
KR20120096764A (en) | Functional food composition for the oral purpose with anti-inflammatory activity and it's method of manufacturing | |
JP2006016330A (en) | Fat-burning accelerating agent | |
CN107280008A (en) | A kind of dietary supplements and its preparation method and application | |
Hrelia et al. | Quercetin and its metabolites in heart health | |
KR102185919B1 (en) | Composition contaning herbal mixture extract for improving, alleviating or treating side-effect of anticancer drug | |
KR101738206B1 (en) | A composition comprising the complex extract of Poncirus trifoliata and Cinnamommum cassia for treating or preventing allergy desmatitis | |
KR101934810B1 (en) | Preparation for improving blood circulation comprising oriental medicinal extracts | |
CN107456504A (en) | A kind of dietary supplements and its preparation method and application | |
CN107441109A (en) | A kind of dietary supplements and its preparation method and application | |
KR101119647B1 (en) | Torilis japonica extracts compositions for treating or preventing inflammatory diseases | |
KR101131719B1 (en) | Pulsatilla koreana extracts compositions for treating or preventing inflammatory diseases | |
CN107518399A (en) | A kind of dietary supplements and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171024 |
|
WD01 | Invention patent application deemed withdrawn after publication |